TY - JOUR
T1 - The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library
AU - Kawaguchi, Tomohiro
AU - Kato, Shunsuke
AU - Otsuka, Kazunori
AU - Watanabe, Gou
AU - Kumabe, Toshihiro
AU - Tominaga, Teiji
AU - Yoshimoto, Takashi
AU - Ishioka, Chikashi
N1 - Funding Information:
We thank Shuang-Yin Han and Wen Liu for their contribution to the construction of the p53 mutation library. We also thank Yuka Fujimaki for technical assistance. This study was supported in part by grants-in-aid from the Ministry of Education and Science, Sports and Culture (to CI and SK) and the Gonryo Medical Foundation (CI).
PY - 2005/10/20
Y1 - 2005/10/20
N2 - Tumor suppressor p53 forms a homo-tetramer through its COOH-terminal oligomerization domain and acts as a sequence-specific transcription factor. We have analysed the interrelation among the transcriptional activities, the structure and the cancer-related mutations in the oligomerization domain by using a comprehensive missense mutation library. Here, we examined the ability of 184 mutant p53s in the domain to form an oligomer by expressing these mutant p53s in yeast, and compared the data with the previous information. We showed that specific residues in the α-helix and the β-strand of the oligomerization domain were critical for both oligomer formation and sequence-specific transactivation, and the activities were closely related. In particular, the α-helix was more sensitive to amino-acid substitutions than the β-strand. We found identity in the interrelation between the two activities, that is, monomer mutants were transcriptionally inactive whereas dimer and tetramer mutants retained their transcriptional activities. In TP53 mutation databases, a small number of mutations have been reported in this domain. Surprisingly, most do not encode p53s defective in functional properties. These results indicate that, although oligomer formation is essential for p53 transactivation function, the inactivation of oligomer formation and therefore the inactivation of transactivation may not be essential for tumor suppression by p53 because they do not lead to oncogenic proteins.
AB - Tumor suppressor p53 forms a homo-tetramer through its COOH-terminal oligomerization domain and acts as a sequence-specific transcription factor. We have analysed the interrelation among the transcriptional activities, the structure and the cancer-related mutations in the oligomerization domain by using a comprehensive missense mutation library. Here, we examined the ability of 184 mutant p53s in the domain to form an oligomer by expressing these mutant p53s in yeast, and compared the data with the previous information. We showed that specific residues in the α-helix and the β-strand of the oligomerization domain were critical for both oligomer formation and sequence-specific transactivation, and the activities were closely related. In particular, the α-helix was more sensitive to amino-acid substitutions than the β-strand. We found identity in the interrelation between the two activities, that is, monomer mutants were transcriptionally inactive whereas dimer and tetramer mutants retained their transcriptional activities. In TP53 mutation databases, a small number of mutations have been reported in this domain. Surprisingly, most do not encode p53s defective in functional properties. These results indicate that, although oligomer formation is essential for p53 transactivation function, the inactivation of oligomer formation and therefore the inactivation of transactivation may not be essential for tumor suppression by p53 because they do not lead to oncogenic proteins.
KW - Oligomerization
KW - Transactivation
KW - p53
UR - http://www.scopus.com/inward/record.url?scp=27144509290&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27144509290&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1208839
DO - 10.1038/sj.onc.1208839
M3 - Article
C2 - 16007150
AN - SCOPUS:27144509290
SN - 0950-9232
VL - 24
SP - 6976
EP - 6981
JO - Oncogene
JF - Oncogene
IS - 46
ER -